Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

9,958 public trials 2,018 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Recruiting

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

NCT04830137

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +36 more
Locations
  • City of Hope Duarte, California, United States
  • University of California Irvine Orange, California, United States
  • University of California San Francisco Medical Center San Francisco, California, United States
  • Sarah Cannon Research Institute at Colorado Blood Cancer Institute Denver, Colorado, United States
View all 16 locations
View Trial Details
Recruiting

Study of Iberdomide, Bortezomib, Dexamethasone With Isatuximab Added on Demand for ND-NTE MM Patients

NCT05272826

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Cross Cancer Institute Edmonton, Alberta, Canada
  • NL Health Services St. John's, Newfoundland and Labrador, Canada
  • QEII Health Science Centre Halifax, Nova Scotia, Canada
  • London Health Sciences Centre London, Ontario, Canada
View Trial Details
Recruiting

A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma

NCT06153251

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +13 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCSF Helen Diller Medical Center at Parnassus Heights San Francisco, California, United States
  • Stanford University Medical Center Stanford, California, United States
View all 19 locations
View Trial Details
Recruiting

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

NCT04065399

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +16 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University Of California Care Medical Group - Norris Comprehensive Cancer Center And Hospital Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 57 locations
View Trial Details

Related conditions